We are live on ! Find out more
COCHW icon

Envoy Medical Warrant

57 hedge funds and large institutions have $8.83M invested in Envoy Medical Warrant in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

56% more capital invested

Capital invested by funds: $5.67M → $8.83M (+$3.16M)

30% more funds holding

Funds holding: 4457 (+13)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
57
Holders Change
+13
Holders Change %
+29.55%
% of All Funds
0.87%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
3
Reduced
3
Closed
8
Calls
$6.66M
Puts
Net Calls
+$6.66M
Net Calls Change
+$950K

COCHW Hedge Fund Activity: Q4 2021 in Review

57 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q4 2021, worth a combined $8.83M — up 56% from $5.67M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new COCHW positions and 8 closed out — a net gain of 14 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Aristeia Capital, opening a new position worth an estimated $652K. The largest seller was Goldman Sachs, cutting an estimated $225K.

  • 57 institutional investors held Envoy Medical Warrant (COCHW) as of Q4 2021, up from 44 in Q3 2021.
  • Funds reported $8.83M of Envoy Medical Warrant stock for Q4 2021, up 56% quarter-over-quarter.
  • 22 funds opened new Envoy Medical Warrant positions in Q4 2021 and 8 closed out, a net change of +14 holders.
  • The largest Envoy Medical Warrant buyer in Q4 2021 was Aristeia Capital, an estimated $652K added.
  • The largest Envoy Medical Warrant seller in Q4 2021 was Goldman Sachs, an estimated $225K sold.

Based on aggregated 13F filings for Q4 2021.